Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts by Philipp Capetian et al.
fncel-10-00245 October 20, 2016 Time: 17:9 # 1
METHODS
published: 24 October 2016
doi: 10.3389/fncel.2016.00245
Edited by:
Lavinia Alberi,
University of Fribourg, Switzerland
Reviewed by:
Hansen Wang,
University of Toronto, Canada
Shwetal Mehta,
Barrow Neurological Institute, USA
Valarmathi Mani Thiruvanamalai,
University of Illinois
at Urbana–Champaign, USA
*Correspondence:
Philipp Capetian
philipp.capetian@neuro.uni-
luebeck.de
†These authors have contributed
equally to this work.
Received: 21 July 2016
Accepted: 06 October 2016
Published: 24 October 2016
Citation:
Capetian P, Azmitia L, Pauly MG,
Krajka V, Stengel F, Bernhardi E-M,
Klett M, Meier B, Seibler P,
Stanslowsky N, Moser A, Knopp A,
Gillessen-Kaesbach G, Nikkhah G,
Wegner F, Döbrössy M and Klein C
(2016) Plasmid-Based Generation
of Induced Neural Stem Cells from
Adult Human Fibroblasts.
Front. Cell. Neurosci. 10:245.
doi: 10.3389/fncel.2016.00245
Plasmid-Based Generation of
Induced Neural Stem Cells from
Adult Human Fibroblasts
Philipp Capetian1,2*†, Luis Azmitia3†, Martje G. Pauly1, Victor Krajka1, Felix Stengel1,
Eva-Maria Bernhardi1, Mariana Klett4, Britta Meier1, Philip Seibler1,
Nancy Stanslowsky5, Andreas Moser2, Andreas Knopp6, Gabriele Gillessen-Kaesbach7,
Guido Nikkhah8, Florian Wegner5, Máté Döbrössy4 and Christine Klein1
1 Institute of Neurogenetics, University of Lübeck, Lübeck, Germany, 2 Department of Neurology, University of Lübeck,
Lübeck, Germany, 3 Department of Neurosurgery, University of Kiel, Kiel, Germany, 4 Laboratory of Stereotaxy and
Interventional Neuroscience, Department of Stereotactic and Functional Neuroscience, University Medical Center Freiburg,
Freiburg im Breisgau, Germany, 5 Department of Neurology, Hannover Medical School, Hanover, Germany, 6 Institute of
Physiology, University of Kiel, Kiel, Germany, 7 Institute of Human Genetics, University of Lübeck, Lübeck, Germany,
8 Department of Neurosurgery, University of Erlangen-Nuremberg, Erlangen, Germany
Direct reprogramming from somatic to neural cell types has become an alternative
to induced pluripotent stem cells. Most protocols employ viral expression systems,
posing the risk of random genomic integration. Recent developments led to plasmid-
based protocols, lowering this risk. However, these protocols either relied on continuous
presence of a variety of small molecules or were only able to reprogram murine
cells. We therefore established a reprogramming protocol based on vectors containing
the Epstein-Barr virus (EBV)-derived oriP/EBNA1 as well as the defined expression
factors Oct3/4, Sox2, Klf4, L-myc, Lin28, and a small hairpin directed against
p53. We employed a defined neural medium in combination with the neurotrophins
bFGF, EGF and FGF4 for cultivation without the addition of small molecules.
After reprogramming, cells demonstrated a temporary increase in the expression of
endogenous Oct3/4. We obtained induced neural stem cells (iNSC) 30 days after
transfection. In contrast to previous results, plasmid vectors as well as a residual
expression of reprogramming factors remained detectable in all cell lines. Cells
showed a robust differentiation into neuronal (72%) and glial cells (9% astrocytes, 6%
oligodendrocytes). Despite the temporary increase of pluripotency-associated Oct3/4
expression during reprogramming, we did not detect pluripotent stem cells or non-neural
cells in culture (except occasional residual fibroblasts). Neurons showed electrical activity
and functional glutamatergic synapses. Our results demonstrate that reprogramming
adult human fibroblasts to iNSC by plasmid vectors and basic neural medium without
small molecules is possible and feasible. However, a full set of pluripotency-associated
transcription factors may indeed result in the acquisition of a transient (at least partial)
pluripotent intermediate during reprogramming. In contrast to previous reports, the
EBV-based plasmid system remained present and active inside the cells at all time
points.
Keywords: direct reprogramming, plasmid based reprogramming, induced neural stem cells, episomal vectors,
adult human fibroblasts, lineage conversion
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INTRODUCTION
Reprogramming of somatic cells to induced pluripotent stem cells
(iPSC) has opened up an entirely new perspective of obtaining
patient-specific cell lines that can be further differentiated into
the desired cell type (Takahashi et al., 2007). The employed
culture techniques are, however, usually technically demanding
and labor-intensive, the differentiation protocols complex and
thus prompted the development of protocols for direct lineage
conversion of somatic cells (Kelaini et al., 2014). In terms of
direct neural reprogramming, two major approaches can be
distinguished: The first one aims at reprogramming somatic
cells into mature post-mitotic neurons (termed induced neurons
(iN)), resulting in a limited number of derived neurons and
requiring repeated reprogramming (Caiazzo et al., 2011; Pfisterer
et al., 2011). The second approach aims at deriving neural
precursors or stem cells that are still proliferative [induced neural
stem cells (iNSC)] (Kim et al., 2011, 2014; Han et al., 2012),
which increases the feasibility of applications demanding high
cell numbers [for reviews see (Hermann and Storch, 2013) and
(Mertens et al., 2016)]. The first protocols for reprogramming
toward iNSC relied on retro- and lenti-viral expression systems
(Kim et al., 2011; Thier et al., 2012). Concerns associated with
the genomic integration of viral DNA led to protocols using
either non-integrating Sendai virus (Lu et al., 2013) or episomal
plasmids (Wang et al., 2012). However, these protocols were
based on the addition of small molecules. A recent study was
successful in overcoming this limitation by employing plasmid
vectors with a set of reprogramming factors in conjunction with
the oriP/EBNA1 expression system derived from the Ebstein-Barr
virus (Kim et al., 2016). This expression system keeps plasmids
as replicating episomes for a limited amount of time until being
expelled from the cells at a later time point (Van Craenenbroeck
et al., 2000). The published protocol demonstrated the feasibility
of this approach for murine cells, however, without mentioning
results for human cells. We therefore sought to establish an
induction protocol for human adult fibroblasts to iNSC based on
plasmid transfection of reprogramming factors in combination
with basic neural medium and pro-neural factors without
addition of small molecules. In addition to the characterization of
proliferating and differentiated cells, we focused on the detection
of persisting plasmid DNA and residual factor expression. Since
the employed reprogramming factors are the same as in iPSC
generation, it is perhaps not surprising that there is evidence from
murine cells for a transient pluripotent step (Maza et al., 2015).
We therefore tested for transient endogenous expression of the
pluripotency-associated factor Oct3/4 as a potential indicator of
such an occurrence in our human cellular model.
MATERIALS AND METHODS
Cell Culture
We obtained fibroblast cultures from skin biopsies from three
healthy human control individuals after giving informed consent
(after approval of the ethics boards of the Universities of
Freiburg and Lübeck). Cells proliferated in basic fibroblast
medium (for exact medium composition see Supplementary
Table 1). We repeated all reprogramming experiments at least
three times for each line. Reprogramming started by a single
round of electroporation of 500 K cells using the human dermal
fibroblast kit together with a Nucleofector device (Lonza, Basel,
Switzerland) following the manufacturer’s protocol (preset U-23).
We used three plasmids in combination (1 µg of DNA of each
plasmid): (1) pCXLE-hOct3/4-shp53-F (Addgene plasmid 27077)
expressing the cDNA for human Oct3/4 under the control of a
CAG promoter and a small hairpin RNA directed against human
p53 under the control of the murine U6 promoter. (2) pCXLE-
hSK (Addgene plasmid 27078) expressing the cDNA of human
SOX2 and KLF4 separated by a 2A peptide under the control
of a CAG promoter. (3) pCXLE-hUL (Addgene plasmid 27080;
Okita et al., 2011) expressing the cDNA of human Lmyc and
Lin28 separated by a 2A peptide under the control of a CAG
promoter. All three plasmids contained the Epstein-Barr virus
(EBV) latent origin of replication system (oriP) and expressed
the Epstein-Barr virus nuclear antigen (EBNA1) under control
of a CAG promoter. Control cells were transfected with 1 µg of a
plasmid of a comparable size but with no reprogramming factor
expression [pCXLE-eGFP (Addgene plasmid 27082; Okita et al.,
2011)] expressing enhanced green fluorescent protein (eGFP)
under control of a CAG promoter. Next, we plated the cells
on a culture dish coated with BD Matrigel (MG, Cornig). Cells
were visualized on an Axiovert 200M microscope (Zeiss, Jena,
Germany).
Basic fibroblast medium was replaced step-wise every other
day with N2B27 medium containing 20 ng/ml basic fibroblast
growth factor (bFGF), 10 ng/ml FGF-4, and 10 ng/ml epidermal
growth factor (EGF, all from Peprotech, Hamburg, Germany).
Emerging neural structures were picked and replated on MG
coated culture dishes in the same medium. When reaching
confluence, cells were detached with accutase (life technologies,
Carlsbad, CA, USA) and replated at a 1:5 ratio (referred to
as proliferative conditions in the following text). For detailed
analysis, a total of three fibroblast lines from healthy adult donors
were reprogrammed with three clones per line.
For clonal analysis, cells were plated at very low density
(50 cells/ml) on a culture dish coated with MG. Emerging
single colonies were picked under the microscope and cultured
accordingly. We used a total number of three clonal lines from
three different fibroblast lines for further experiments. iPSCs
serving as a control for expression of pluripotency-associated
factors were generated by retroviral mediated overexpression
of standard reprogramming factors (OCT4, SOX2, KLF4 and
C-MYC) in human adult fibroblasts and cultured as described
elsewhere (Seibler et al., 2011).
For differentiation and patterning experiments, cells were kept
in N2B27 medium and bFGF, FGF4 and EGF were omitted.
For differentiation, 20 ng/ml brain-derived neurotrophic factor
(BDNF), 10 ng/ml glial cell line-derived neurotrophic factor
(GDNF), 10 ng/ml insulin-like growth factor 1 (IGF-1, all
from Peprotech, Hamburg, Germany), 0.5 mM dibutyril
cyclic adenosine-monophosphate (dbcAMP, Enzo Life Sciences,
Farmingdale, NY, USA), and 10 µM DAPT (Tocris, Ellisville,
MO, USA) were added for 30 days.
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Karyotyping
Kryotyping was performed after passage 15 by Giemsa Trypsin
banding. In short, colonies were incubated with a colcemid
solution (10 µg/ml in HBSS) for 3 h to arrest cells in metaphase.
Cells were treated with trypsin (0.25%) and the enzymatic
reaction was stopped with Amniomax solution (Invitrogen,
Darmstadt, Germany). Cells were centrifuged at 300 × g for
10 min and the pellet was resuspended in 4 ml hypotonic
potassium chloride solution (5.62%). Cells were incubated for
5 min at 37◦C and centrifuged at 300 × g for 10 min. Cells were
resuspended and fixed in 5 ml glacial acetic acid and methanol
(1:3) and subsequently centrifuged for 7 min at 350× g. This step
was repeated once. Finally, most of the supernatant was removed
and cells were resuspended. Cell suspension was dropped onto
cold slides and dried at 100◦C for 1 h. Giemsa solution (5%) was
added and incubated for 5 min. Slides were washed in distilled
water two times, dried at room temperature and sealed with cover
slips. Chromosomes of 10 – 12 cells in total were analyzed.
Immunofluorescence and Confocal
Imaging
Cells were plated on 12 mm glass coverslips (Karl Hecht,
Sondheim, Germany) coated with poly-d-lysine (Sigma-Aldrich,
St. Louis, MO, USA) and laminin (Roche, Basel, Switzerland).
Cells were fixed with 4% PFA (Merck, Darmstadt, Germany),
stained (for buffers, a detailed staining protocol and employed
antibodies see Supplementary Tables 2–4) and mounted on glass
slides (Menzel Gläser, Braunschweig, Germany). Imaging was
performed with an LSM 710 confocal laser scanning microscope
(Zeiss, Jena, Germany) equipped with the ZEN black software
(Zeiss, Jena, Germany). For quantification, eight representative
sample images were taken and cells counted with the ImageJ
software.
PCR Analysis
RNA or genomic DNA was extracted with the QIAamp mini
DNA or RNA kit (Qiagen, Venlo, Netherlands) according to
the manufacturer’s protocol. 500 ng of RNA were transcribed
to cDNA with the First Strand cDNA Synthesis Kit (Thermo
Fisher Scientific, Waltham, MA, USA). If possible, primers for
cDNA analysis were designed to skip one or more introns; the
sequences for plasmid-specific primers were adopted from the
original publication (Okita et al., 2011; for a complete list of
employed primers see Supplementary Table 5). qPCR reaction
and analysis was carried out with the LC SYBR Green Mix
(Fermentas, Vilnius, Lithuania) in a Lightcycler 480 (Roche,
Basel, Switzerland, see Supplementary Figure 1 for a detailed
description of the conditions). Relative expression levels to the
house keeping gene β-actin were calculated for cDNA and
to GAPDH for genomic DNA by the relative standard curve
method. (the latter values were divided by two in order to obtain
values per genome). Standard curves were generated by serial
dilutions of linearized plasmid templated containing the target
sequence of the corresponding primer pair. Expression levels of
endogenous Oct3/4 and SOX2 were evaluated by designing a
primer pair with the reverse primer binding to the 3’-untranslated
region of the SOX2-mRNA. A regular PCR was performed
on cDNA or plasmid DNA with a taq polymerase (Thermo
Fisher Scientific, Waltham, MA, USA, see Supplementary Table 6
for a detailed description of the conditions) followed by gel
electrophoresis (1% agarose). A 100-bp DNA ladder (New
England Biolabs, Ipswich, MA, USA) was used to evaluate the
correct product size.
Electrophysiological Measurements
For electrophysiological measurements, cells were plated on
coated glass coverslips and differentiated as described above; only
the differentiation period was extended to 90 days. Patch pipettes
were formed from borosilicate glass (Science Products, Hofheim,
Germany) with a P1000 universal puller (Sutter Instruments,
Novato, CA, USA) to final resistances of 3 to 4 M when
filled with the internal solution consisting of 153 mM KCl,
1 mM MgCl2, 10 mM HEPES, 5 mM EDTA and 2 mM Mg-
ATP, adjusted to pH 7.3 with KOH (305 mOsm). The bath
solution contained 142 mM NaCl, 8 mM KCl, 1 mM CaCl2,
6 mM MgCl2, 10 mM glucose and 10 mM HEPES, adjusted to
pH 7.4 with NaOH (325 mOsm). Tetrodotoxin (TTX, 1 µM),
tetraethylammoniumchloride (TEA, 10 mM), 2,3-dihydroxy-6-
nitro-7-sulphamoyl-benzo(f)quinoxaline (NBQX, 10 µM), and
memantine (100 µM, all purchased from Sigma-Aldrich)
were diluted in the bath solution and applied via gravity
using a modified SF-77B perfusion fast-step system (Warner
Instruments, Hamden, CT, USA) as published (Wegner et al.,
2008). Whole-cell patch clamp experiments were performed
at 20–22◦C under optical control (inverted microscope, Zeiss,
Jena, Germany). Cells with leak currents <100 pA were used
for further analysis. Whole-cell currents were low-pass filtered
at 2.9 kHz, digitized at 10 kHz using an EPC-10 amplifier
(HEKA, Lambrecht, Germany) and analyzed with Patch Master
(HEKA).
Statistical Analysis
Obtained results were computed with the help of a statistics
software (GraphPadPrism 6.0, GraphPad Software, San Diego,
CA, USA). For comparison of MAP2-positive cells between
undifferentiated and differentiated states, we employed the paired
t-test. The two-way ANOVA in combination with Dunnett’s
multiple comparison test served for computing the time-
dependent expression of endogenous Oct3/4. The effect of NBQX
and memantine on neurons was calculated by a one-way ANOVA
in combination with Bonferroni’s multiple comparison test.
A result was considered significant at p-values < 0.05.
RESULTS
Reprogramming and Establishment of
iNSC Lines
After 10 days in culture, first morphological changes in cells
transfected with the reprogramming plasmids became visible
(Figure 1a). At about day 30 post-transfection, colonies
reached a sufficient size (Figure 1b) for being picked manually
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FIGURE 1 | Evaluation of the reprogramming process: (a) Change in morphology with colony formation of transfected cells at day 7 post-transfection with the
reprogramming plasmids. Scale bar = 100 µM. (b) A typical neural colony at the time of picking. Scale bar = 100 µm. (c) Rosette formation of cells after initial
picking and replating. Scale bar = 50 µm. (d) Expression levels of endogenous Oct3/4 at different time points after transfection. Expression levels of iPSC are given
as control. (three independent cell lines, two technical replicates, 2-way-ANOVA with Dunnett’s multiple comparison test, p = 0.0002, error bars correspond to
standard deviation). ∗∗ = very significant.
and propagated under adherent conditions. Each round of
transfection yielded between 10 and 20 expanding colonies,
thus resulting in a reprogramming efficiency between
0.02 and 0.04% per cell (based on a number of 500,000
transfected cells). Mainly during the first passage, cells formed
characteristic rosette-like structures (Figure 1c) and could be
propagated for at least 25 passages without loss of proliferative
capacity. Cells transfected with non-reprogramming plasmids
did not show any morphological changes (Supplementary
Figure 4).
Transient Expression of Endogenous
Oct3/4 during the Reprogramming
Process
We checked for a potential intermediate (partial) pluripotent
step during reprogramming by quantifying expression levels of
endogenous Oct3/4 at different time points after transfection
by qPCR(day 0 as baseline, day 1, 2, 5, 10, 30 and 90).
Relative expression levels to the house-keeping gene beta-
Actin (bAct) at day 10 and 30 showed a significant increase
compared to baseline and decreased thereafter (Figure 1d,
two-way ANOVA with Dunnett’s multiple comparison test,
p = 0.0002). Relative expression levels of Oct3/4 in iPSC
served as comparison (they were not included in the statistical
analysis).
iNSC under Proliferative Conditions
Under proliferative conditions (after 10 passages), 57% of
the cells expressed the homeodomain protein PAX6, an early
marker of neuroectodermal differentiation and radial glia of
the dorsal telencephalon (Callaerts et al., 1997, p. 6). 67%
were positive for the intermediate filament nestin expressed in
neural stem cells, 30% stained positive for βIII-tubulin, a marker
associated with neuronal progenitors and immature neurons
(Figures 2a–c). The only non-neural cellular phenotype we
sporadically identified consisted of alpha-smooth muscle actin-
positive cells (Supplementary Figure 2). Pan-cytokeratin- and
alpha-fetoprotein (AFP)-positive cells could not be identified
(data not shown). Cells positive for the pluripotency marker
NANOG were also absent (data not shown).
Derivation of Clonal Lines and Analysis
of Tripotency
After removal of bFGF, FGF4, and EGF and addition of
BDNF, GDNF, IGF-1, dbcAMP, and DAPT for at least
30 days, single cell-derived colonies on MG showed neural
trilineage differentiation capacity, as evidenced by positive
immunostaining for neuronal microtubule associated protein
2 (MAP2), astrocytic glial fibrillary acidic protein (GFAP;
Figure 3a), and the oligodendrocyte marker galactosylceramidase
(GALC; Figure 3b). Percentage of total cells (as determined by
DAPI staining) was 72% for MAP2, 8.9% for GFAP and 5.7% for
GALC (Figure 3c).
Karyotyping, Evaluation of Residual
Plasmid Expression, and Activation of
SOX2 Expression
Cells demonstrated a stable karyotype as determined by
karyogram (Figure 4a). Although episomal vectors were used
for reprogramming, cells contained 0.74 copies per cell under
proliferative conditions, as determined by qPCR with a plasmid-
specific primer pair, in contrast to 23879.4 copies per cell
at day 5 post-transfection (Figure 4b). The absent peak in
the melting curve for untransfected fibroblasts (Supplementary
Figure 3) demonstrated the specificity of the assay. In iNSC
lines, the presence of endogenous SOX2 mRNA could be
demonstrated by PCR, while being absent in untransfected
fibroblasts. Absence of a reaction product when using the
reprogramming plasmid encompassing the SOX2 sequence as
template demonstrated the specificity for endogenous SOX2
mRNA (Figure 4c). A variable but clearly measurable residual
expression of reprogramming factors was detected by qPCR, in
particular of L-MYC (Figure 4d).
Differentiation and Neuronal Subtypes
Differentiation for at least 30 days led to subsequent maturation
of the iNSC represented by a significant increase (means
of eight high power fields from four lines each, paired
t-test, p < 0.001) of MAP2-positive cells with long and
elaborate processes from 7% under proliferative conditions
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FIGURE 2 | Cells under proliferative conditions: Representative confocal images of iNSCs under proliferative conditions: (a) Pax6-positive nuclei
(green), counterstaining with DAPI (blue). Scale bar = 30 µm. (b) Nestin (red), bIII-tubulin (green), DAPI (blue). Scale bar = 30 µm. (c) Cell counts of different cell
markers in relation to total cell number (means of eight high power fields from three iNSC cell lines, error bars correspond to standard deviation). Confocal images of
cells after differentiation derived from a clonal line.
FIGURE 3 | Differentiation of iNSC: (a) GFAP (green), MAP2 (red) and DAPI (blue). Scale bar = 30 µm. (b) GALC (green) and DAPI (blue). Scale bar = 10 µm.
(c) Cell counts after differentiation of three clonal lines in relation to total cell number (means of eight high power fields from three iNSC cell lines, error bars
correspond to standard deviation).
to 75% at the end of the differentiation (Figures 5a–c).
Further quantification of the neuronal subtypes after 30 days
of differentiation revealed 61.9% of the MAP2-positive cells
to be BRN2-positive (a marker of glutamatergic upper-layer
cortical neurons; Figures 6a,e). We tried staining glutamatergic
neurons directly for vesicular glutamate transporter 1 (VGLUT1),
however, the punctuate staining of synaptic terminals in the
absence of a somatic signal prevented quantification (Figure 6f).
20.4% of differentiated neurons stained positive for GABA
(Figures 6b,e), 21.7% were positive for tyrosine hydroxylase
(TH, Figures 6c,e). Only very occasionally (<0.01%), neurons
expressed choline-acetyltransferase (CHAT), the rate-limiting
enzyme of acetylcholine synthesis. The latter exhibited a relatively
large soma with very elaborate processes (however, void of MAP2,
Figure 6d). Ctip2-positive (a marker for lower-layer cortical
neurons) cells were absent (data not shown).
Electrophysiological Assessment
After 90 days of differentiation, neuronal properties of cells
harboring a neuronal morphology were analyzed: Cells exerted
a negative resting membrane potential of −37.5 ± 2.1 mV.
Large outward currents were reliably induced by depolarizing
voltage steps of 10 mV from a holding potential of −70 to
40 mV. These currents showed voltage dependence and kinetic
characteristics of potassium currents, which were inhibited by
the potassium channel blocker TEA (10 mM) applied to the
extracellular solution (Figure 7a). In response to depolarization,
cells also generated sodium inward currents that were blocked
by the sodium channel blocker TTX (1 µM; Figure 7a). Peak
currents were normalized for cell size based on the capacitance
of the cell membrane (pA/pF, Figure 7b). In current-clamp
experiments, 96% (n = 25/26) of the neurons fired TTX-
sensitive APs with average amplitudes of 44.6 ± 2.3 mV and
durations of 3.3 ± 0.3 ms, 24% (n = 6/26) fired multiple
APs upon depolarization (Figure 7c). The functional properties
of differentiated iNSC derived neurons are summarized in
Table 1.
Spontaneous post-synaptic currents (PSCs) were found in
40% of the cells (n = 10/26). Application of 10 µM of the
potent and competitive AMPA receptor antagonist NBQX led
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FIGURE 4 | Evaluation of genomic stability and continuous expression of reprogramming factors: (a) Normal karyogram of an iNSC line. (b) Copy numbers
of plasmid per genome as quantified by qPCR at day 5 after transfection and under proliferative conditions (two independent experiments with three cell lines, two
technical replicates, error bars correspond to standard deviation). (c) Gel electrophoresis of a PCR with a primer pair specific for the endogenous SOX2 sequence
(left): A reaction product is only present for the cDNA derived from iNSC lines, not from fibroblasts or when using the reprogramming plasmid carrying the SOX2
sequence. Equal levels of b-Actin for the cell lines are demonstrated on the right. Supercoiled plamid DNA is visible at the top (asterisk). (d) qPCR analysis of residual
reprogramming factor expression in relation to the house keeping gene beta-actin (bAct) under proliferation of iNSCs (means of three independent iNSC lines, two
technical replicates, error bars correspond to standard deviation).
FIGURE 5 | Evaluation of neuronal maturation through differentiation: Confocal image of MAP2-positive cells (red) before (a) and after differentiation (b),
nuclear counterstaining with DAPI (blue). Scale bar = 20 µm. (c) Change in percentage of MAP2-positive cells relative to total cells before and after differentiation
(means of eight high power fields from three iNSC cell lines each, paired t-test, p < 0.0001). ∗∗∗∗ = extremely significant.
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FIGURE 6 | Neuronal identity after differentiation: Representative confocal images of cells after 30 days of differentiation: In green the upper-layer
cortical marker Brn2 (a), GABA (b), TH (c), CHAT (d). (a-d) MAP2 (red), DAPI (blue). Scale bars = 20 µm (a-c), 50 µm (d). (e) Percentage of different neuronal
markers in relation to MAP2-positive cells (means of eight high power fields from three iNSC cell lines, error bars correspond to standard deviation). (f) Puncate
staining of VGLUT1 adjecent to neuronal soma and processes corresponding to glutamatergic synapses.
to a significant reduction of the frequency but not of the
amplitude of PSCs. Application of the non-competitive NMDA
receptor antagonist memantine (100 µM) had no effect on
either parameter (n = 11, one-way ANOVA, p = 0.028 for
frequency after NBQX application, for the remainder p > 0.05,
Figures 7d,e). Staining for vesicular glutamate transporter 1
(VGLUT1), demonstrated its presence on neuronal surfaces in
culture after differentiation (Figure 6f).
DISCUSSION
Virus-mediated gene delivery requires higher biosafety levels and
is more technically demanding than plasmid-based protocols.
Therefore, plasmid-based transfection protocols allow the
application of reprogramming in laboratories without a virus
facility. For our protocol, we chose a well-established and effective
reprogramming system (Okita et al., 2011). This system employs
five transcription factors (Oct3/4, Sox2, Klf4, Lin28 and L-myc).
A small hairpin RNA silencing p53 expression included for
enhancing the reprogramming process, as it has been shown
that p53 suppresses successful cellular reprogramming (Hong
et al., 2009). While other protocols sought to reduce the number
of factors employed (Mitchell et al., 2014), our priority was to
increase the effectivity of the reprogramming process. Therefore,
we accepted a higher number of reprogramming factors.
Reprogramming and Establishment of
iNSC Lines
Based on the published experience that employing basic
neural medium in combination with growth factors (promoting
growth of neural precursors and stem cells) was sufficient for
reprogramming of murine fibroblasts (Kim et al., 2016), we
avoided small molecules promoting neural induction (Lu et al.,
2013). The rationale behind this approach was to interfere as
little as possible with the ongoing reprogramming process, as
many small molecules employed during neural reprogramming
also serve as morphogens and could change regional identity
(e.g., purmorphamine and CHIR99021; Kriks et al., 2011). The
composition of the neural medium followed a protocol for
reprogramming of murine fibroblasts (Kim et al., 2014), which
includes the well-established growth factors FGF-2 and EGF
(Hitoshi et al., 2004; Deleyrolle and Reynolds, 2009), but also
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 October 2016 | Volume 10 | Article 245
fncel-10-00245 October 20, 2016 Time: 17:9 # 8
Capetian et al. Plasmid Based Generation of iNSC
FIGURE 7 | Electrophysiological characterization: Whole-cell patch-clamp recordings of cells after 90 days of differentiation. (a) The presence of
sodium and potassium channels was demonstrated by short inward and long outward currents upon depolarization. Outward currents were blockable by the
potassium channel inhibitor TEA, inward currents by the sodium channel blocker TTX. (b) Ion currents normalized for cell sizes based on the capacitance of the cell
membrane (pA/pF). (c) A neuron firing multiple action potentials upon depolarization. (d) Significant reduction of the frequency but not amplitude of PSCs after
application of the inhibitor for AMPA-receptors NBQX. The NMDA-receptor-antagonist memantine (100 µM) shows no significant effect on either parameter (11
neurons analyzed, one-way ANOVA, p = 0.028 for frequency after NBQX application, for the rest p > 0.05). (e) Representative tracings of PSCs of one neuron
before and after the application of 10 µM NBQX or 100 µM memantine. TEA, tetraethylammoniumchloride; TTX, tetrodotoxin; NBQX,
2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)quinoxaline. ∗ = significant.
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TABLE 1 | Electrophysiological properties by whole-cell patch clamping of
neurons after 90 days of differentiation (number of recorded neurons = 26,
three independent cell lines).
Functional properties
Peak Na +peak current −96.2 ± 8.9 pA/pF
Peak K +peak current 150.6 ± 13.1 pA/pF
Resting membrane potential −37.5 ± 2.1 mV
Membrane capacitance 23.2 ± 2.0 pF
Input resistance 608.4 ± 78.1 MOhm
Cells with APs 25 (96%)
Cells with multiple APs 6 (24%)
Cells with spontaneous APs 10 (40%)
AP amplitude 44.6 ± 2.3 mV
AP duration 3.3 ± 0.3 ms
AHP amplitude 19.6 ± 1.7 mV
Time to peak AHP 11.0 ± 0.8 ms
AHP, after hyperpolarization; AP, action potential.
the less commonly used factor FGF-4. Nonetheless, evidence
exists for it promoting the proliferation of neural stem cells
(Kosaka et al., 2006). We were able to show that transfected
adult fibroblasts changed their morphology as early as 7 days
after transfection, reaching an appropriate size for mechanical
isolation after roughly 30 days. The efficiency of the method
lies between 0.02 and 0.04%, i.e., the range reported in the
original publication which used the plasmid constructs for
reprogramming to iPSC (Okita et al., 2011). Another protocol
overexpressing PAX6 and SOX2 by plasmid transfection in
fibroblasts for reprogramming to neural precursor-like cells
reported an efficiency of 0.05% (Maucksch et al., 2012). Protocols
using retroviral particles achieved higher rates of reprogramming
(0.5–1%; Ring et al., 2012). We would attribute this to
the in general lower transfection efficiency of plasmid-based
transfection protocols compared to retroviral infection. (For an
overview of published integration-free conversion protocols to
NSC see Supplementary Table 7).
Transient Expression of Endogenous
Oct3/4 during the Reprogramming
Process
Combining the expression of pluripotency factors (Okita et al.,
2011) with basic neural medium and neural growth factors (Ying
et al., 2003; Hitoshi et al., 2004) in order to achieve neural
reprogramming, raises the question whether cells transit through
an intermediate pluripotent step. The first publication on iNSC
addressed this issue by employing a pNANOG-eGFP construct
as a marker of (temporary) pluripotency (Kim et al., 2011)
and revealed that no NANOG-positive cells developed with the
reported protocol for direct neural reprogramming. A recent
publication, however, called these findings into question. This
study employed an inducible polycistronic expression cassette
of Oct3/4, SOX2, KLF4 and C-MYC in combination with a
NANOG-CRE reporter system. The vast majority of murine
fibroblasts temporally passed through a pluripotent step during
transdifferentiation toward iNSC (Maza et al., 2015). As there
is no published data for human cells, we addressed this in
our work. As we found that human fibroblasts expressed low
levels of transcription factors associated with pluripotency (e.g.,
Oct3/4), employing a reporter construct did not seem feasible.
Therefore, we chose to quantify endogenous expression levels
of Oct3/4 during the initial phase of reprogramming. Ten days
after transfection, expression levels increased significantly and
remained elevated until the first passage after 30 days. During
long-term culturing, levels decreased again to the baseline level.
Furthermore, upon long-term proliferation, we could not detect
any NANOG-positive cells by immunofluorescence. Notably, we
cannot determine whether the intermediate cell types possess
bona-fide pluripotency. However, increased expression levels of
Oct3/4 are associated with the epiblast stage in vivo and decrease
in cells of the primitive neural plate (Iwafuchi-Doi et al., 2011,
p. 5). However, the initial reports meticulously characterizing
the expression of Oct3/4 during murine embryogenesis by in
situ hybridization found this factor expressed in the primitive
neuroectoderm (Palmieri et al., 1994, p. 3). Taken together,
further studies will be necessary to conclusively answer the
question of transient pluripotency during the reprogramming
process. Obviously, employing a set of reprogramming factors
unable to reprogram somatic cells to a pluripotent state might
help avoiding this problem: Indeed, one recent study was
successful in reprogramming somatic cells toward neural stem
cells without overexpressing Oct3/4 (Kim et al., 2016).
iNSC under Proliferative Conditions
After replating, cells homogeneously reformed into
the characteristic rosette-like growth pattern known of
neuroepithelial precursors in vitro (Elkabetz et al., 2008).
As already reported for iPSC-derived culture systems, this cell
type is not stable under cultivation under FGF/EGF-containing
conditions and the proliferative NSCs acquire a phenotype
reminiscent of radial glia (symmetric proliferation, bipolar
morphology, Nestin and PAX6-positivity, and tripotency; Conti
et al., 2005; Elkabetz et al., 2008; Conti and Cattaneo, 2010). As
indeed the majority (67%) of the reprogrammed cells expressed
nestin and 57% expressed PAX6 under proliferative conditions,
they showed a corresponding morphology and proved able to
derive neurons and glia in clonally derived cultures. Thus, there
is a solid body of evidence indicating that they acquire features
associated with NSC. However, 30% of cells stained positive
for bIII-tubulin [considered the earliest marker for neuronal
commitment (Fanarraga et al., 1999)], whereas MAP2 as a
marker of mature neuronal cells was found in only 7% of the
cells. This demonstrates that even under proliferative conditions,
a certain degree of spontaneous neuronal commitment and even
differentiation occurs, a feature also reported in the context of
reprogramming protocols employing retroviral particles for gene
delivery (Kim et al., 2011).
Residual Expression of Reprogramming
Factors
The mean number of persisting plasmid copies per cell was 0.7
(ranging between 0.0006 and 2.8 between lines). Our plasmids
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contained the EBV latent origin of replication system (oriP)
and expressed the Epstein-Barr virus nuclear antigen (EBNA1).
This allows replication during cell cycle while still persisting as
episomal elements during long-term passaging with only very
infrequent genomic integration (Westphal et al., 1998). As we
did not perform fluorescence in-situ hybridization (FISH) on
our cells, we cannot rule out a stable genomic integration. These
findings differ from the original publication which employed
the reprogramming plasmids to derive iPSCs and detected an
ongoing presence of plasmid sequence only in two out of seven
lines (Okita et al., 2011). Another study employing vectors
containing the oriP/EBNA1 system for direct reprogramming
could not detect ongoing expression of reprogramming factors
(Kim et al., 2016). However, other studies evaluating the
feasibility of oriP/EBNA1 as an expression system in human
and murine stem cells demonstrated a prolonged expression (Ali
Hosseini Rad et al., 2015).
We were able to demonstrate that reprogrammed cells
expressed endogenous SOX2, a prerequisite for early neural
precursor identity (Graham et al., 2003, p. 2; Ferri et al., 2013,
p. 2). Conversely, fibroblast cultures did not express Sox2 before
reprogramming. This argues in favor of the fact that expression
of the reprogramming factors in conjunction with the neural
medium led to a profound change in the cellular identity toward a
neural stem cell lineage. However, due to the sustained expression
of reprogramming factors, we cannot fully rule out the fact that
iNSC identity would still be dependent on them.
Differentiation and Evaluation of
Neuronal Subtypes
As expected from neural stem cells, removal of mitogens,
addition of neurotrophic factors (in our case BDNF, GDNF, IGF
and dbcAMP) and the pro-neurogenic, NOTCH-inhibiting small
molecule DAPT, led to differentiation, reflected by cells forming
elaborate MAP2-positive processes but also an increase of the
number of MAP2-positive cells. Astrocytes and oligodendrocytes
were also present after differentiation of clonally derived iNSC,
clearly demonstrating the tripotency of the proliferative cells.
Further analysis of neuronal subtypes revealed a predominance
of neurons with the upper-layer cortical marker BRN2 over
GABA and TH and a virtual absence of CHAT-positive cells.
It has been reported that even in the absence of morphogens,
neural cells derived from iPSCs acquire a predominantly anterior
identity (Pankratz et al., 2007). Ongoing culturing of neural stem
cells depends on mitogens like FGF2 and maintains neurogenic
potency, however, leads to a relaxation of the stringency of
positional identities: NSCs derived from embryonic cortex
ventralize partly in the presence of FGF2 during culturing and
result in GABAergic neurons (Bithell et al., 2008). Based on our
findings, iNSCs behave according to their counterparts derived
from iPSCs or primary sources.
Electrophysiological Assessment
After 90 days of differentiation, cells showed functional neuronal
membrane properties including a negative membrane potential,
fast inward sodium and outwardly rectifying potassium currents
in 96% of analyzed cells. More mature functional properties
like spontaneous firing of action potentials and the firing of
multiple action potentials upon depolarization were only present
in a fraction of cells (40 and 24%, respectively). Previously
published reports on neurons from directly reprogrammed
neural precursors did not provide a detailed analysis of
electrophysiological properties. Our data is, however, in line with
findings from iPSC-derived neurons, of which even after long-
term differentiation, only a fraction of neuronal cells acquire
a completely mature electrophysiological phenotype (Pre et al.,
2014). Reasons for that are most likely suboptimal cellular culture
conditions, as addition of glial cells to developing neurons
enhances their maturity by secreted factors (Blondel et al., 2000;
Boehler et al., 2007; Pre et al., 2014).
Based on the presence of the upper cortical layer marker
BRN2 in 61.9% of MAP2-positive cells, we consider the majority
of neurons to be glutamatergic. The spontaneous miniature
synaptic activity was reduced by inhibition of AMPA but not
of NMDA receptors, which is in line with the notion that
maturation of glutamatergic synapses is associated with a shift
from predominant NMDA to AMPA receptor types (Groc et al.,
2006). Furthermore, all cells analyzed showed PSCs, further
supporting maturity of glutamatergic synapses.
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